These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 26014604)
1. Progressive multiple sclerosis exhibits decreasing glutamate and glutamine over two years. MacMillan EL; Tam R; Zhao Y; Vavasour IM; Li DK; Oger J; Freedman MS; Kolind SH; Traboulsee AL Mult Scler; 2016 Jan; 22(1):112-6. PubMed ID: 26014604 [TBL] [Abstract][Full Text] [Related]
2. Evidence for early neurodegeneration in the cervical cord of patients with primary progressive multiple sclerosis. Abdel-Aziz K; Schneider T; Solanky BS; Yiannakas MC; Altmann DR; Wheeler-Kingshott CA; Peters AL; Day BL; Thompson AJ; Ciccarelli O Brain; 2015 Jun; 138(Pt 6):1568-82. PubMed ID: 25863355 [TBL] [Abstract][Full Text] [Related]
3. Longitudinal Metabolite Changes in Progressive Multiple Sclerosis: A Study of 3 Potential Neuroprotective Treatments. John NA; Solanky BS; De Angelis F; Parker RA; Weir CJ; Stutters J; Carrasco FP; Schneider T; Doshi A; Calvi A; Williams T; Plantone D; Monteverdi A; MacManus D; Marshall I; Barkhof F; Gandini Wheeler-Kingshott CAM; Chataway J; J Magn Reson Imaging; 2024 Jun; 59(6):2192-2201. PubMed ID: 37787109 [TBL] [Abstract][Full Text] [Related]
4. Metabolite changes in normal-appearing gray and white matter are linked with disability in early primary progressive multiple sclerosis. Sastre-Garriga J; Ingle GT; Chard DT; Ramió-Torrentà L; McLean MA; Miller DH; Thompson AJ Arch Neurol; 2005 Apr; 62(4):569-73. PubMed ID: 15824254 [TBL] [Abstract][Full Text] [Related]
5. Brain Metabolite Changes in Patients with Relapsing-Remitting and Secondary Progressive Multiple Sclerosis: A Two-Year Follow-Up Study. Obert D; Helms G; Sättler MB; Jung K; Kretzschmar B; Bähr M; Dechent P; Diem R; Hein K PLoS One; 2016; 11(9):e0162583. PubMed ID: 27636543 [TBL] [Abstract][Full Text] [Related]
6. Association of Cortical Lesions With Regional Glutamate, GABA, Madsen MA; Považan M; Wiggermann V; Lundell H; Blinkenberg M; Romme Christensen J; Sellebjerg F; Siebner HR Neurology; 2024 Jul; 103(1):e209543. PubMed ID: 38870443 [TBL] [Abstract][Full Text] [Related]
7. Brainstem metabolites in multiple system atrophy of cerebellar type: 3.0-T magnetic resonance spectroscopy study. Takado Y; Igarashi H; Terajima K; Shimohata T; Ozawa T; Okamoto K; Nishizawa M; Nakada T Mov Disord; 2011 Jun; 26(7):1297-302. PubMed ID: 21370263 [TBL] [Abstract][Full Text] [Related]
8. Increased concentrations of glutamate and glutamine in normal-appearing white matter of patients with multiple sclerosis and normal MR imaging brain scans. Tisell A; Leinhard OD; Warntjes JB; Aalto A; Smedby Ö; Landtblom AM; Lundberg P PLoS One; 2013; 8(4):e61817. PubMed ID: 23613944 [TBL] [Abstract][Full Text] [Related]
9. Higher glutamate+glutamine and reduction of N-acetylaspartate in posterior cingulate according to age range in patients with cognitive impairment and/or pain. Fayed N; Andrés E; Viguera L; Modrego PJ; Garcia-Campayo J Acad Radiol; 2014 Sep; 21(9):1211-7. PubMed ID: 24981958 [TBL] [Abstract][Full Text] [Related]
10. Metabolite concentrations in supraventricular white matter from teenage to early old age: A short echo time 1H magnetic resonance spectroscopy (MRS) study. Raininko R; Mattsson P Acta Radiol; 2010 Apr; 51(3):309-15. PubMed ID: 20170295 [TBL] [Abstract][Full Text] [Related]
11. Proton MRS in acute traumatic brain injury: role for glutamate/glutamine and choline for outcome prediction. Shutter L; Tong KA; Holshouser BA J Neurotrauma; 2004 Dec; 21(12):1693-705. PubMed ID: 15684761 [TBL] [Abstract][Full Text] [Related]
12. Evidence of elevated glutamate in multiple sclerosis using magnetic resonance spectroscopy at 3 T. Srinivasan R; Sailasuta N; Hurd R; Nelson S; Pelletier D Brain; 2005 May; 128(Pt 5):1016-25. PubMed ID: 15758036 [TBL] [Abstract][Full Text] [Related]
13. Effects of age and sex on the concentrations of glutamate and glutamine in the human brain. Hädel S; Wirth C; Rapp M; Gallinat J; Schubert F J Magn Reson Imaging; 2013 Dec; 38(6):1480-7. PubMed ID: 23564615 [TBL] [Abstract][Full Text] [Related]
14. Longitudinal changes of cerebral glutathione (GSH) levels associated with the clinical course of disease progression in patients with secondary progressive multiple sclerosis. Choi IY; Lee P; Hughes AJ; Denney DR; Lynch SG Mult Scler; 2017 Jun; 23(7):956-962. PubMed ID: 27620894 [TBL] [Abstract][Full Text] [Related]
15. Single voxel proton magnetic resonance spectroscopy in post-stroke depression. Glodzik-Sobanska L; Slowik A; McHugh P; Sobiecka B; Kozub J; Rich KE; Urbanik A; Szczudlik A Psychiatry Res; 2006 Dec; 148(2-3):111-20. PubMed ID: 17088051 [TBL] [Abstract][Full Text] [Related]
16. Determinants of disability in multiple sclerosis at various disease stages: a multiparametric magnetic resonance study. Pulizzi A; Rovaris M; Judica E; Sormani MP; Martinelli V; Comi G; Filippi M Arch Neurol; 2007 Aug; 64(8):1163-8. PubMed ID: 17698707 [TBL] [Abstract][Full Text] [Related]
17. Neurochemical changes in welders revealed by proton magnetic resonance spectroscopy. Chang Y; Woo ST; Lee JJ; Song HJ; Lee HJ; Yoo DS; Kim SH; Lee H; Kwon YJ; Ahn HJ; Ahn JH; Park SJ; Weon YC; Chung IS; Jeong KS; Kim Y Neurotoxicology; 2009 Nov; 30(6):950-7. PubMed ID: 19631686 [TBL] [Abstract][Full Text] [Related]